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Recent evidence points to important contri-
butions of exposure to environmental neuro-
toxicant chemicals in the marked increase in
neurodevelopmental disorders, including
learning disabilities, attention deficit and
hyperactivity disorder, and autism spectrum
disorders (Szpir 2006). Despite the increasing
recognition of the importance of evaluating
developmental neurotoxicity in safety assess-
ment (Claudio et al. 2000; Eriksson 1997;
Tilson 1995, 2000), the fact remains that, of
> 70,000 commercial chemicals in current
use, neurotoxicity of any kind has been evalu-
ated in < 10% (Landrigan et al. 1994), and
obviously, developmental neurotoxicity in a
substantially smaller fraction. Even now, of the
2,000–3,000 new chemicals released each year,
two-thirds never get tested for neurotoxicity,
let alone developmental effects (Claudio et al.
2000), whereas between 25–40% will eventu-
ally prove to be neurotoxic (Boyes 2001).
Among the many potential developmental
neurotoxicants, the greatest attention has been
paid to pesticides, in light of their widespread
use in the home and in agriculture [U.S.
Environmental Protection Agency (EPA)
2006]. Here, too, despite the institution of a
standardized protocol for developmental neu-
rotoxicity, few compounds have actually been
tested relative to the total number of concern,
even after mandated call-ins for data by the
U.S. EPA (Makris 2006; U.S. EPA 2006).
A number of factors contribute to the
dearth of information on developmental
neurotoxicity relative to the demonstrated
need for such knowledge. First, there is the
essential dichotomy between the requirement
to evaluate large numbers of compounds and
the costly, cumbersome protocols prescribed
for standard tests in animals (Colborn 2006;
Makris 2006; Slotkin 2004b; U.S. EPA
2006). Second, testing compounds one at a
time may produce results that are difﬁcult to
compare (Colborn 2006; U.S. EPA 2006), in
large measure because the presumed mecha-
nisms and targets are based on systemic or
central nervous system effects in adults that
may be unrelated to developmental neuro-
toxicity (Colborn 2006; Makris 2006; Slotkin
2004b, 2005). The organophosphate insecti-
cides provide an archetype. Although it was
originally thought that all organophosphates
act similarly through irreversible inhibition of
acetylcholinesterase, it is now evident that
their adverse effects on brain development
actually involve multiple mechanisms, many
of which are unrelated to cholinesterase inhi-
bition (Casida and Quistad 2004; Costa
2006; Pope 1999; Slotkin 2004a, 2004b,
2005). Accordingly, the relative potencies of
organophosphates toward cholinesterase inhi-
bition and/or systemic toxicity do not neces-
sarily correlate with their propensity to elicit
developmental neurotoxicity (Costa 2006;
Pope 1999; Qiao et al. 2001; Slotkin et al.
2006a, 2006b).
One strategy proposed to resolve this
problem is the use of screening techniques
based on cell culture systems or lower organ-
isms as the first stage of evaluation, thus
enabling subsequent animal studies to focus
on those compounds most likely to cause
developmental neurotoxicity (Costa 1998;
Slotkin 2004b). This approach was recently
endorsed in a report from the Inspector
General of the U.S. EPA (U.S. EPA 2006) as
well as by outside groups (Colborn 2006;
Costa 1998, 2006; Slotkin 2004b). In the pre-
sent study we use PC12 cells, a standard
in vitro model for neuronal development
(Teng and Greene 1994) that has already been
used to characterize essential features of the
developmental neurotoxicity of organophos-
phates (Bagchi et al. 1995, 1996; Crumpton
et al. 2000a, 2000b; Das and Barone 1999;
Flaskos et al. 1994; Jameson et al. 2006b; Li
and Casida 1998; Nagata et al. 1997; Qiao
et al. 2001, 2005; Song et al. 1998; Tuler
et al. 1989). As transformed cells, the PC12
line has an advantage over cultured primary
neurons, which do not maintain cell division
and thus cannot detect adverse effects on the
cell cycle, a likely neurotoxic target; further-
more, primary neurons do not provide a uni-
form population either in terms of cell types
or differentiation state, rendering their use for
screening problematic. Upon exposure to
nerve growth factor (NGF), PC12 cells gradu-
ally exit the mitotic cycle and begin to differ-
entiate, developing axonal projections,
electrical excitability, and the characteristics of
two distinct phenotypes, cholinergic and cate-
cholaminergic neurons (Fujita et al. 1989;
Song et al. 1998; Teng and Greene 1994).
Accordingly, the PC12 model enables the
detection of toxicant actions that target cell
replication as well as the events involved in
differentiation and the phenotypic emergence
of speciﬁc neuronal features. The PC12 model
has been used to characterize the potential
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BACKGROUND: In light of the large number of chemicals that are potential developmental neuro-
toxicants, there is a need to develop rapid screening techniques. 
OBJECTIVES: We exposed undifferentiated and differentiating neuronotypic PC12 cells to different
organophosphates (chlorpyrifos, diazinon, parathion), a carbamate (physostigmine), an organochlo-
rine (dieldrin), and a metal (divalent nickel; Ni2+) and examined indices of cell replication and dif-
ferentiation for both short- and long-term exposures. 
RESULTS: In undifferentiated cells, all the agents inhibited DNA synthesis, with the greatest effect
for diazinon, but physostigmine eventually produced the largest deﬁcits in the total number of cells
after prolonged exposure. The onset of differentiation intensiﬁed the adverse effects on DNA syn-
thesis and changed the rank order in keeping with a shift away from noncholinergic mechanisms
and toward cholinergic mechanisms. Differentiation also worsened the effects of each agent on cell
number after prolonged exposure, whereas cell growth was not suppressed, nor were there any
effects on viability as assessed with trypan blue. Nevertheless, differentiating cells displayed signs of
oxidative stress from all of the test compounds except Ni2+, as evidenced by measurements of lipid
peroxidation. Finally, all of the toxicants shifted the transmitter fate of the cells away from the
cholinergic phenotype and toward the catecholaminergic phenotype. 
CONCLUSIONS: These studies point out the feasibility of developing cell-based screening methods
that enable the detection of multiple end points that may relate to mechanisms associated with
developmental neurotoxicity, revealing some common targets for disparate agents.
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6 September 2006]neurotoxicity of a wide variety of compounds
in addition to the organophosphates, includ-
ing nicotine, metals, and organometals
(Abreu-Villaça et al. 2005; Benters et al. 1996;
Crumpton et al. 2001; Matsuoka and Igisu
1996; Parran et al. 2003; Shafer 1998; Tian
et al. 2000); largely, these have been done one
compound or class at a time and with a focus
on individual cellular targets or processes,
rather than within a framework of compara-
tive changes with a global impact on neuro-
development. Critical for the use of PC12 cells
in modeling the developmental neurotoxicity
of compounds such as the organophosphates,
the cholinergic and catecholaminergic pheno-
types are among the prominent in vivo targets
for these compounds (Aldridge et al. 2005;
Barone et al. 2000; Dam et al. 1999; Jameson
et al. 2006b; Pope 1999; Rice and Barone
2000; Slotkin 2004a; Slotkin et al. 2002;
Vidair 2004). Nevertheless, PC12 cells share
the limitations common to in vitro models,
namely an inability to assess neuronal–glial
interactions or architectural aspects of regional
development, maternal–fetal or neonatal
pharmacokinetics, and related issues of
bioavailability, dose, and bioeffective concen-
trations (Costa 1998; Slotkin 2004b).
Although chlorpyrifos has been the most
studied compound in the PC12 model (Bagchi
et al. 1995, 1996; Crumpton et al. 2000a,
2000b; Das and Barone 1999; Jameson et al.
2006b; Qiao et al. 2001, 2005; Song et al.
1998), similarities and differences have been
noted for other organophosphates such as
diazinon and for nonorganophosphate
cholinesterase inhibitors of the carbamate class,
with physostigmine as the prototype (Jameson
et al. 2006b; Qiao et al. 2001). In the present
work, we compared chlorpyrifos, diazinon, and
a third organophosphate (parathion) with
physostigmine, an organochlorine (dieldrin),
and a metal (Ni2+).These additional com-
pounds were chosen for specific mechanistic
and environmental reasons. First, all of them
except physostigmine appear on the registry of
Superfund Chemicals (U.S. National Library
of Medicine 2006) and thus represent signiﬁ-
cant disposal problems. For diazinon, expo-
sures of inner-city women during pregnancy
are comparable to those seen with chlorpyrifos
(Whyatt et al. 2002). The developmental
neurotoxicity of diazinon has been studied
sparingly, but shows a spectrum of effects simi-
lar to chlorpyrifos in both the PC12 model
(Axelrad et al. 2002; Qiao et al. 2001) and in
evaluations with lower organisms (Morale et al.
1998), albeit with a potency proﬁle differing
from the comparative effects of the two
organophosphates on cholinesterase (Slotkin
et al. 2006a). For parathion, despite U.S.
restrictions, use and exposure remain common
in agricultural communities around the world
(Fenske et al. 2002). With chronic exposure to
frankly toxic doses, parathion inhibits protein
synthesis in the fetus (Gupta et al. 1984),
whereas at lower exposures, it displays devel-
opmental toxicity that is not dependent on
cholinesterase inhibition per se (Atterberry
et al. 1997) but rather reflects differences in
neural adaptations to exposure (Howard and
Pope 2002; Karanth and Pope 2003; Liu
et al. 1999). However, compared with chlor-
pyrifos and diazinon, parathion exhibits
greater systemic toxicity relative to its propen-
sity to produce developmental neurotoxicity
(Slotkin et al. 2006a), again echoing the view
that organophosphates are distinct in their
profiles for adverse effects on the immature
brain. Although the effects of parathion have
not been evaluated in PC12 cells in a devel-
opmental context, other neural culture sys-
tems have successfully recapitulated the
adverse effects on neurodevelopment and
confirmed its dissociation from mechanisms
involving cholinesterase inhibition (Monnet-
Tschudi et al. 2000; Zurich et al. 2000). The
carbamate physostigmine is effective as a
cholinesterase inhibitor and shares some
organophosphate-like effects on cell differentia-
tion, but it is much less capable of eliciting
immediate antimitotic actions (Jameson et al.
2006b; Qiao et al. 2001); it is considerably less
effective than organophosphates as a develop-
mental neurotoxicant in lower organisms
(Buznikov et al. 2003).
In contrast to the organophosphates,
organochlorines such as dieldrin have been
less studied for developmental neurotoxicity,
but the available evidence suggests a much
more restricted range of mechanisms. Acute
dieldrin intoxication produces fetal neural
damage (Uzoukwu and Sleight 1972), and at
lower concentrations, dieldrin interacts with
γ-amino butyric acid (GABAA) channels in the
fetal brain (Brannen et al. 1998); however, the
long-term consequences of these lower-dose
effects have not been evaluated. We suspect
that the same strategies adopted for studies of
organophosphates at the cellular level might
prove useful in uncovering biomarkers and
mechanisms for developmental neurotoxicity
of dieldrin; for example, short-term, high-con-
centration dieldrin exposure of PC12 cells
elicits oxidative stress and apoptosis differen-
tially according to neurotransmitter phenotype
(Kitazawa et al. 2001, 2003). Similarly, nickel
compounds readily cross the placenta and
accumulate in fetal tissues, including the
brain, at concentrations that greatly exceed
maternal levels (Jacobsen et al. 1978). Indeed,
the nickel concentration just from normal
dietary and environmental exposure in human
fetuses is comparable to that of lead, up to
2 μg/g dry weight in soft tissues including the
brain (Casey and Robinson 1978). Although
the developmental neurotoxicity of nickel is
almost completely unexplored, there is every
reason to believe this metal may be as injuri-
ous as lead. In PC12 cells, Ni2+ interferes with
the gating of calcium just as does lead or cad-
mium (Benters et al. 1996) in a manner that is
dependent on the state of differentiation of
the cells, so that the inclusion or exclusion of
NGF makes a great difference in susceptibility
(Nikodijevic and Guroff 1992). In developing
sea urchins, Ni2+ produces phenotypic abnor-
malities that bear some resemblance to those
caused by the organophosphates (Buznikov
et al. 2003; Hardin et al. 1992).
Our overall strategy was to focus on aspects
of neurodevelopment that lend themselves to
rapid screening and that permit ready compar-
isons of targets involving cell replication,
growth, and differentiation. We compared the
effects of different concentrations and dura-
tions of exposure of PC12 cells to chlorpyrifos,
diazinon, parathion, physostigmine, dieldrin,
and Ni2+ in undifferentiated and differentiated
states, evaluating indices of cell replication
(radiolabeled thymidine incorporation into
DNA), cell number, cell growth, viability (try-
pan blue exclusion), and phenotype. Each
neural cell contains only a single nucleus
(Winick and Noble 1965), so that the DNA
content (micrograms of DNA per culture dish
in the present study) reﬂects the total number
of cells (Song et al. 1998). Indices of growth
were provided by measurements of protein
subfractions related to cell size and membrane
surface area (Jameson et al. 2006a; Thai et al.
1996). The total protein/DNA ratio rises
with cell enlargement, and the membrane/total
protein ratio falls as a consequence of the
decreased surface-to-volume ratio. On the
other hand, with the onset of differentiation,
the development of neuritic projections neces-
sitates a rise in the relative contribution of
membrane proteins, so that the increase in the
membrane/total protein ratio gives an indica-
tion of augmented membrane “complexity.”
The effects on cell number, size, and cell sur-
face area were compared to those on viability
(evaluated by trypan blue exclusion) and lipid
peroxidation (evaluated by thiobarbituric acid-
reactive species; TBARS). To characterize the
catecholaminergic and cholinergic phenotypes,
we assessed the ratio of activities of tyrosine
hydroxylase (TH) to choline acetyltransferase
(ChAT), the respective biosynthetic enzymes
for dopamine and acetylcholine (Teng and
Greene 1994; Jameson et al. 2006a, 2006b).
Materials and Methods
Cell cultures. Because of the clonal instability of
the PC12 cell line (Fujita et al. 1989), the
experiments were performed on cells that had
undergone fewer than five passages, and all
studies were repeated several times with differ-
ent batches of cells. As described previously
(Crumpton et al. 2000a; Qiao et al. 2003; Song
et al. 1998), PC12 cells (1721-CRL; American
Slotkin et al.
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seeded onto 100-mm poly-D-lysine-coated
plates in RPMI-1640 medium (Invitrogen,
Carlsbad, CA) supplemented with 10% inacti-
vated horse serum (Sigma Chemical Co.,
St. Louis, MO), 5% fetal bovine serum (Sigma
Chemical Co.), and 50 μg/mL penicillin strep-
tomycin (Invitrogen). Cells were incubated
with 7.5% CO2 at 37°C, and the medium was
changed every 2 days. For studies in the undif-
ferentiated state, cells were seeded at varying
densities so that, regardless of the total time of
incubation, the cells would reach a ﬁnal con-
ﬂuence of 60–70%. Twenty-four hours after
seeding, the medium was changed to include
the various test substances: chlorpyrifos (Chem
Service, West Chester, PA), diazinon (Chem
Service), parathion (Chem Service), physo-
stigmine (Sigma Chemical Co.), dieldrin
(Chem Service), or NiCl2 (Sigma Chemical
Co.). Because of their poor water solubility, the
pesticides were dissolved in dimethyl sulfoxide
(Sigma Chemical Co.), achieving a ﬁnal con-
centration of 0.1% in the culture medium;
accordingly, all cultures included this vehicle,
which had no effect on the PC12 cells (Qiao
et al. 2001, 2003; Song et al. 1998).
For studies in differentiating cells, 3 × 106
cells were seeded; 24 hr later, the medium was
changed to include 50 ng/mL 2.5 S murine
NGF (Invitrogen), and each culture was
examined under a microscope to verify the
subsequent outgrowth of neurites. The test
agents were added concurrently with the start
of NGF treatment.
DNA synthesis. To initiate the measure-
ment of DNA synthesis, the medium was
changed to include 1 μCi/mL of [3H]thymi-
dine (specific activity, 2 Ci/mmol; GE
Healthcare, Piscataway, NJ) along with the
continued inclusion of the test substances.
After 1 hr, the medium was aspirated and cells
were harvested in ice-cold water. Duplicate
aliquots of each sample were treated with 10%
trichloroacetic acid and sedimented at
1,000 × g for 15 min to precipitate macro-
molecules. The resulting pellet was washed
once with additional trichloroacetic acid and
then with 75% ethanol. The final pellet was
hydrolyzed with 1 M KOH overnight at 37°C
and neutralized with 6 M HCl, and the DNA
was precipitated with ice-cold 5% trichloro-
acetic acid and resedimented. The supernatant
solution, comprising solubilized RNA and pro-
tein, was discarded. The DNA-containing pel-
let was hydrolyzed in 5% trichloroacetic acid
for 15 min at 90°C and resedimented, and an
aliquot of the supernatant solution was
counted for radiolabel. Another aliquot was
assayed for DNA spectrophotometrically by
absorbance at 260 nm. Previous work has
demonstrated quantitative recovery of DNA by
these techniques (Bell et al. 1986; Slotkin et al.
1984). Incorporation values were corrected to
the amount of DNA present in each culture to
provide an index of macromolecule synthesis
per cell (Winick and Noble 1965).
Cell number and size. For determinations
of DNA content, total protein/DNA ratio and
membrane/total protein ratio, the medium was
aspirated and the culture was rinsed with a
buffer consisting of 154 mM NaCl and 10 mM
sodium phosphate (pH 7.4). Cells were har-
vested in ice-cold buffer and homogenized
(Polytron; Brinkmann Instruments, Westbury,
NY), and aliquots were withdrawn for measure-
ments of DNA and total protein using dye-
binding methods (Trauth et al. 2000). To
prepare the cell membrane fraction, the
homogenates were sedimented at 40,000 × g
for 10 min and the pellet was washed and
resedimented. Aliquots of the ﬁnal resuspension
were then assayed for membrane protein
(Smith et al. 1985).
Enzyme activities. Cells were harvested as
described above and were disrupted by homog-
enization in a ground-glass homogenizer ﬁtted
with a ground-glass pestle, using a buffer con-
sisting of 154 mM NaCl and 10 mM sodium-
potassium phosphate (pH 7.4). Aliquots were
withdrawn for measurement of DNA and
protein (Smith et al. 1985).
ChAT assays (Lau et al. 1988) were con-
ducted in 60 μL of a buffer consisting of
60 mM sodium phosphate (pH 7.9), 200 mM
NaCl, 20 mM choline chloride, 17 mM
MgCl2, 1 mM EDTA, 0.2% Triton X-100,
0.12 mM physostigmine, and 0.6 mg/mL
bovine serum albumin (Sigma Chemical Co.),
containing a final concentration of 50 μM
[14C]acetyl-coenzyme A (specific activity
60 mCi/mmol, diluted with unlabeled com-
pound to 6.7 mCi/mmol; PerkinElmer Life
Sciences, Boston, MA). The amount of pro-
tein used in each assay was adjusted to main-
tain activity within the linear range. Blanks
contained homogenization buffer instead of
the tissue homogenate. Samples were pre-
incubated for 15 min on ice and transferred
to a 37°C water bath for 30 min; the reaction
was terminated by placing the samples on ice.
Labeled acetylcholine was then extracted and
counted in a liquid scintillation counter and
the activity was calculated as nanomoles syn-
thesized per hour per microgram DNA.
TH activity was measured using [14C]tyro-
sine as a substrate and trapping the evolved
14CO2 after coupled decarboxylation with dopa
decarboxylase (Lau et al. 1988; Waymire et al.
1971). Homogenates were sedimented at
26,000 × g for 10 min to remove storage vesi-
cles containing catecholamines, which interfere
with TH activity, and assays were conducted
with 100 μL aliquots of the supernatant solu-
tion in a total volume of 550 μL. Each assay
(pH 6.1) contained ﬁnal concentrations of 910
μM FeSO4, 55 μM unlabeled L-tyrosine (Sigma
Chemical Co.), 9.1 μM pyridoxal phosphate
(Sigma Chemical Co.), 36 μM β-mercapto-
ethanol, and 180 μM 2-amino-6,7-dimethyl-
4-hydroxy-5,6,7,8-tetrahydropteridine HCl
(Sigma Chemical Co.), all in a buffer of
180 mM sodium acetate and 1.8 mM sodium
phosphate (pH 6.1). Each assay contained
0.5 μCi of generally labeled [14C]tyrosine (spe-
ciﬁc activity, 438 mCi/mmol; Sigma Chemical
Co.) as substrate, and blanks contained buffer
in place of the homogenate. Activity was calcu-
lated on the same basis as for ChAT.
Thiobarbituric acid-reactive species.
TBARS determinations were carried out by a
modiﬁcation (Qiao et al. 2005) of published
procedures (Guan et al. 2003). Cells were har-
vested with 150 mM NaCl and 10 mM
sodium phosphate (pH 7.4) and sonicated for
20 sec; aliquots were withdrawn for measure-
ments of DNA and protein (Smith et al. 1985;
Trauth et al. 2000). Another aliquot was added
to 0.5 volumes of 15% trichloroacetic acid, fol-
lowed by 1.5 volumes of thiobarbituric acid
reagent: 0.67 g thiobarbituric acid (Sigma
Chemical Co.) dissolved in 80 mL of 1 M
NaOH, titrated to pH 3.5 with 20 mL glacial
acetic acid. Samples were incubated for 60 min
at 90–100°C, cooled to room temperature,
and sedimented at 3,000 × g for 10 min. The
supernatant solution was resedimented and
absorption was determined at 532 nm, using
malonaldehyde bis(dimethylacetal) (Sigma
Chemical Co.) as a standard. To give the
TBARS concentration per cell, values were cal-
culated relative to the amount of DNA.
Viability. To assess cell viability, the cell
culture medium was changed to include trypan
blue (1 volume per 2.5 volumes of medium;
Sigma Chemical Co.) and cells were exam-
ined for staining under 400× magnification,
counting an average of 100 cells per field in
four different ﬁelds per culture.
Data analysis. Data are presented as means
and standard errors. For each type of study,
treatment differences were ﬁrst evaluated with
a global analysis of variance (ANOVA; data
log-transformed whenever variance was hetero-
geneous) incorporating all variables: cell batch
number, treatment, and time. Based on the
main treatment effects and/or interactions of
treatment × time, differences for individual
treatments were evaluated post hoc by Fisher’s
protected least significant difference. For all
tests, signiﬁcance was assumed at p < 0.05. In
the initial test, the results did not vary among
the different batches of cells, so results across
the different batches were combined for pre-
sentation and the indicated number of samples
in each experiment reﬂects the total number of
cultures.
Results
In undifferentiated PC12 cells, even a 1-hr
exposure to a low concentration (5 μM) of each
of the agents elicited a small but statistically
Screening for developmental neurotoxicity
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tion as monitored by the incorporation of
[3H]thymidine into DNA (Figure 1A). Among
the organophosphates, diazinon and parathion
were slightly more effective than chlorpyrifos
(e.g., at 1 hr of exposure, p < 0.03 for diazinon
or parathion vs. chlorpyrifos); for the other
agents, physostigmine and dieldrin were simi-
lar to diazinon, whereas Ni2+ was only about as
effective as chlorpyrifos (p < 0.03 for Ni2+ vs.
diazinon). We then evaluated whether the
response was maintained with continued
exposure to the organophosphates. After
24 hr exposure, all the compounds remained
effective; nevertheless, the response to
parathion disappeared after 4–6 days of con-
tinuous exposure, whereas the effects of chlor-
pyrifos and diazinon remained detectable.
Raising the concentration to 30 μM produced
correspondingly more robust inhibition of
DNA synthesis in undifferentiated cells
(Figure 1B). Again, diazinon remained more
effective than chlorpyrifos with 1 hr of expo-
sure (p < 0.0001), and this relationship
remained over a span of 6 days. At this higher
concentration, the effect of parathion was
maintained throughout the exposure period.
However, physostigmine showed adaptation
by 4 days of exposure, whereas the adverse
effects of the organophosphates, dieldrin, and
Ni2+ remained fully in evidence.
In cells undergoing NGF-induced differ-
entiation, the rate of DNA synthesis was far
lower than in undifferentiated cells and
declined precipitously over the span of
12 days (Figure 1C, note change in ordinate
scale). Nevertheless, inhibitory effects of the
organophosphates and physostigmine were
fully in evidence after 4 days of coexposure
with NGF. Unlike the situation in undiffer-
entiated cells, the response to physostigmine
did not show attenuation with continued
exposure and, in fact, the carbamate had a
greater effect than did the organophosphates
(p < 0.02 vs. chlorpyrifos; p < 0.005 vs. diazi-
non; p < 0.0008 vs. parathion).
In keeping with their ability to inhibit
DNA synthesis, all the test agents produced
significant shortfalls in cell number when
undifferentiated cells were exposed for a
period of 6 days (Figure 2A). Chlorpyrifos
and diazinon each elicited a reduction of
about 10%, whereas parathion was somewhat
more effective (p < 0.01 vs. either chlorpyrifos
or diazinon) and physostigmine substantially
more so (p < 0.0001 vs. chlorpyrifos or diazi-
non; p < 0.004 vs. parathion). Dieldrin and
Ni2+ had effects similar to those of the
organophosphates. In contrast, cell growth
was not suppressed by the organophosphates
or physostigmine and, in fact, there were sig-
nificant elevations in the total protein/DNA
ratio for these agents (Figure 2B). For this
index, there were clear differences between
these compounds and dieldrin or Ni2+, both
of which evoked a signiﬁcant reduction in the
total protein/DNA ratio. In keeping with a
reduction in cell size for these two agents, the
membrane/total protein ratio rose, reﬂecting
the higher surface/volume ratio associated
with smaller cells (Figure 2C). Paradoxically,
chlorpyrifos, parathion, and physostigmine
increased the membrane/total protein ratio,
despite the fact that they also increased the
total protein/DNA ratio, implying that these
agents actually augmented the membrane
complexity of the cells as an accompaniment
to the increase in cell size. Diazinon did not
share these properties.
We next conducted parallel studies for bio-
markers of cell number and size in differentiat-
ing cells at 4 and 8 days of exposure. All of the
agents elicited significant decrements in cell
number across both time points (Figure 3A).
With the exception of Ni2+, the adverse effects
worsened substantially between 4 and 8 days
and were much greater in magnitude than the
Slotkin et al.
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Figure 1. DNA synthesis shown as disintegrations per minute (dpm; mean ± SE) of [3H]thymidine in (A) undifferentiated cells exposed to 5 µM of agent, (B) undiffer-
entiated cells exposed to 30 µM, and (C) differentiating cells exposed to 30 µM and cotreated with NGF (note that scale in C differs from that in A and B). ANOVA
across all treatments and time points (number of determinations for each condition): (A), treatment, p < 0.0001; treatment × time, p < 0.0001 (n = 6–18); (B), treatment,
p < 0.0001; treatment × time, p < 0.0001 (n = 12–30); (C), treatment, p < 0.0001; treatment × time, p < 0.0001 (n = 12–30).
*Signiﬁcantly different from the corresponding control value (p < 0.05).
Figure 2. Indices of cell number and size (mean ± SE) in undifferentiated cells exposed to 30 µM of agent for 6 days. (A) DNA content. (B) Total protein/DNA ratio.
(C) Membrane/total protein ratio. ANOVA across all treatments (number of determinations for each condition): (A) p < 0.0001 (n = 5–10); (B) p < 0.0001 (n = 5–10);
(C) p < 0.0004 (n = 5–10).
*Signiﬁcantly different from the corresponding control value (p < 0.05).
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Exposure time Exposure time Exposure timedeﬁcits seen in undifferentiated cells (note dif-
ferent scales for Figure 2A and 3A). Again, we
did not see evidence for additional impairment
of cell growth: all agents increased the total
protein/DNA ratio signiﬁcantly, with a corre-
spondingly greater effect at 8 days, when cell
number was reduced the most (Figure 3B). On
the other hand, there were biphasic effects on
the membrane/total protein ratio in differenti-
ating cells (Figure 3C). At 4 days of exposure,
the organophosphates had little or no effect on
this marker, whereas physostigmine, dieldrin,
and Ni2+ all elicited a significant reduction.
After 8 days of continuous exposure, the dif-
ferentiating cells showed increases in the
membrane/total protein ratio for chlorpyrifos,
parathion, and dieldrin, whereas the other
three agents had no signiﬁcant effect.
In differentiating cells after 6 days of co-
exposure to NGF and each agent, there were no
significant effects on trypan blue exclusion
(Figure 4A) and the proportion of nonviable
cells was uniformly low in all preparations. In
contrast, we obtained evidence for signiﬁcant
membrane lipid peroxidation, as evidenced by
the TBARS assay (Figure 4B). All of the
organophosphates, as well as physostigmine and
dieldrin, evoked significant elevations in
TBARS, whereas Ni2+ uniquely caused a reduc-
tion. Nevertheless, all the agents produced a
shift away from the cholinergic phenotype and
toward the catecholaminergic phenotype, as
evidenced by a significant increase in the
TH/ChAT ratio (Figure 4C); similar results for
chlorpyrifos and physostigmine have been pub-
lished previously (Jameson et al. 2006b).
Discussion
One of the major concerns about developmen-
tal neurotoxicity is the fact that the targeting of
the immature brain may occur at toxicant
exposures that are nonsymptomatic or that do
not elicit general signs of systemic or cytotoxic-
ity (Boyes 2001; U.S. EPA 2006). In the pre-
sent study, we focused on exposures of PC12
cells to organophosphates, a carbamate, an
organochlorine, and a metal that did not by
themselves elicit general cytotoxic damage as
monitored by trypan blue exclusion.
Furthermore, even the 30 μM concentration
used for most of our studies lies within the
100–1,000× safety factor required for estab-
lishing neurotoxic end points (Boyes 2001;
U.S. EPA 2006); indeed, for the organophos-
phates, fetal exposures in agricultural commu-
nities are likely to be nearly as high (Ostrea
et al. 2002), and similarly, even routine dietary
intake produces brain Ni2+ concentrations
approximating 10 μM (Casey and Robinson
1978). There are three essential ﬁndings in our
study. First, a single agent may target multiple
events in neural cell replication and differentia-
tion, thus spanning a wide range of develop-
mental stages. Second, otherwise unrelated
chemicals that likely possess different originat-
ing mechanisms of action can nevertheless con-
verge on a common set of ﬁnal events in cell
development, producing similar outcomes.
Finally, and perhaps most importantly, our
evaluations show the potential utility of an
approach using neuronotypic cells in culture to
screen suspected developmental neurotoxi-
cants, enabling characterization of vulnerable
stages, likely outcomes, and rank comparisons
of related and unrelated chemicals.
In our earlier work with organophos-
phates, we demonstrated the ability of chlor-
pyrifos to cause immediate inhibition of cell
replication in undifferentiated PC12 cells,
exempliﬁed by a reduction in [3H]thymidine
incorporation into DNA within the ﬁrst hour
of exposure (Song et al. 1998), an effect that
mirrors similar actions on the developing
brain in vivo (Whitney et al. 1995) and that
ultimately leads to deﬁcits in neural cell num-
bers (Slotkin 2004a, 2004b, 2005), just as
seen here in the PC12 model. The effect was
shared by another organophosphate (diazi-
non), whereas a carbamate (physostigmine)
was much less effective (Qiao et al. 2001).
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Figure 3. Indices of cell number and size (mean ± SE) in differentiating cells exposed to 30 µM of agent and cotreated with NGF. (A) DNA content. (B) Total pro-
tein/DNA ratio. (C) Membrane/total protein ratio (note the interrupted ordinate scale). ANOVA across all treatments and both time points (number of determina-
tions for each condition): (A) treatment, p < 0.0001; treatment × time, p < 0.0001 (n = 10–22); (B) treatment, p < 0.0001; treatment × time, p < 0.0001 (n = 10–22); (C)
treatment, p < 0.004; treatment × time, p < 0.0001 (n = 10–22).
*Signiﬁcantly different from the corresponding control value (p < 0.05).
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Figure 4. Indices of viability, oxidative damage, and transmitter phenotype (mean ± SE) in differentiating cells exposed to 30 µM of agent and cotreated with NGF
for 6 days. (A) Trypan blue staining. (B) TBARS (note the interrupted ordinate scale). (C) TH/ChAT activity ratio. ANOVA across all treatments (number of determi-
nations for each condition) (A) not signiﬁcant (n = 10–22); (B) p < 0.0001 (n = 5–10); (C) p < 0.0001 (n = 10–25). 
*Signiﬁcantly different from the corresponding control value (p < 0.05).
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*Importantly, chlorpyrifos oxon had a lesser
action than chlorpyrifos, despite the fact that
it is 1,000-fold more potent toward inhibition
of cholinesterase (Das and Barone 1999).
Furthermore, cholinergic antagonists failed to
block the effect (Song et al. 1998), demon-
strating that the adverse actions of organo-
phosphates on cell replication were separate
from anticholinesterase activity. Here, we
expanded our findings to include another
organophosphate (parathion), an organo-
chlorine (dieldrin), and a metal (Ni2+); com-
pared effects at a threshold concentration of
5 μM, as well as at 30 μM; determined the
persistence over a course of nearly 1 week of
exposure; and evaluated the downstream con-
sequences for cell acquisition and growth.
Although all the organophosphates evoked sig-
nificant reductions in DNA synthesis, diazi-
non was the most effective over a prolonged
time course: after 6 days of continuous expo-
sure, diazinon maintained a significantly
greater inhibitory effect than did either chlor-
pyrifos or parathion. Interestingly, this differs
from the rank order of effects at 1 hr in PC12
cells incubated without the inclusion of serum
proteins (Qiao et al. 2001), where chlorpyrifos
is more effective than diazinon. It is important
to note that the organophosphates show
strong binding to serum proteins both in vivo
and in vitro (Braeckman et al. 1983; Qiao
et al. 2001), which reduces their bioeffective
concentrations. The effect is highest for chlor-
pyrifos, less important for parathion, even
lower for diazinon, and lowest for physo-
stigmine (Braeckman et al. 1983; Sultatos
et al. 1984; Whelpton and Hurst 1990; Wu
et al. 1996). For the present study, serum pro-
teins could not be deleted from the medium
because they are required to maintain cell
growth and viability, and consequently, the
rank order of effects changes so that diazinon
and physostigmine, with their lower binding,
exert greater net effects than would otherwise
be expected. These are not unimportant
details: the actions of the organophosphates
and carbamates in vivo are clearly modiﬁed by
their binding to serum proteins in the circula-
tion. Also, the concentration of these proteins
is lower in the fetus than in the adult (Thom
et al. 1967; Yaffe and Stern 1976), so that at
comparable concentrations of each neuro-
toxicant, the fetus will bear a disproportionate
burden of adverse effects. Additional factors
must be operating to distinguish among the
effects of the different organophosphates. For
example, we found that the ability of
parathion to reduce DNA synthesis at a low
concentration (5 μM) showed eventual adap-
tation, so by 4–6 days of continuous exposure,
its inhibitory actions were no longer evident.
In contrast, chlorpyrifos and diazinon showed
persistence of the effect. Again, these ﬁndings
illustrate that the PC12 model can incorporate
factors such as protein binding that are critical
issues for the developmental neurotoxicity of
disparate compounds in vivo. Based on these
ﬁndings, it might be anticipated that the vari-
ous organophosphates will differ from each
other and from the carbamates in their adverse
effects on brain development, a prediction
that should be pursued in future studies.
Given that organophosphates reduce
DNA synthesis in undifferentiated cells in a
manner different from their ability to inhibit
cholinesterase (Qiao et al. 2001; Song et al.
1998), it is of considerable import that we
obtained a similar result with either dieldrin or
Ni2+, compounds otherwise unrelated to each
other, the organophosphates, or physostig-
mine. This, too, illustrates how disparate neu-
rotoxicants can nevertheless converge on a
common set of functional end points and thus
may share many of the same attributes for
adverse effects on the developing brain in vivo.
In the present study, the consequences were
examined through a series of markers related to
cell acquisition and growth. In the undifferen-
tiated cells, 6 days of continuous exposure to
each of the agents produced a corresponding
decrement in the total number of cells as mon-
itored by DNA content. However, the rank
order did not correspond one-to-one with the
relative effects on DNA synthesis. For cell
acquisition, physostigmine had the greatest
adverse effect, followed by parathion, dieldrin,
and then by chlorpyrifos ≈ diazinon ≈ Ni2+.
Accordingly, there must be other actions of
these agents that inﬂuence the total number of
cells other than their effect on DNA synthesis.
These may include other, rate-limiting steps in
the production of new cells downstream from
DNA synthesis per se, as well as effects on cell
turnover and/or apoptotic loss. We did not
observe any decreases in viability as moni-
tored with trypan blue, but a small, persistent
adverse effect could eventually influence cell
number without being detectable with this
technique. Studies are currently under way to
examine potentially subtle cytotoxic effects or
apoptotic events using gene expression proﬁl-
ing, an approach that may be successful in
elucidating these additional mechanisms.
However, again, the main point is that a rela-
tively facile set of markers in PC12 cells can
detect adverse effects on neural cell acquisi-
tion across a wide array of disparate com-
pounds in a short period of time.
In contrast to their effects on cell number,
the organophosphates and physostigmine did
not suppress cell growth in undifferentiated
PC12 cells, as monitored by the protein/DNA
ratio; in fact, each of these agents evoked a
small but statistically signiﬁcant increase. On
the other hand, both dieldrin and Ni2+ did
reduce the ratio, implying that these agents
simultaneously suppress neural cell acquisition
and cell growth. Again, this in vitro test system
now points the way toward end points that
may differentiate the developmental neurotox-
icity of these two agents from those of the
organophosphates or carbamates. Finally, the
assessment of membrane complexity in undif-
ferentiated cells (membrane/total protein
ratio) indicated further differences among the
agents, with signiﬁcant increases for all except
diazinon. For dieldrin and Ni2+, the increase
in the ratio reflects in part the inhibition of
cell growth, because the geometry of a smaller
cell necessitates a higher surface-to-volume
ratio. However, that cannot explain the
increase for chlorpyrifos, parathion, and
physostigmine, which did not suppress cell
growth; for these agents, either intracellular
organelles are being induced or, alternatively,
they may provide a prodifferentiation signal
that elicits expansion of the membrane surface
as a prelude to neurite outgrowth. Again, this
is in keeping with some of the known effects
of chlorpyrifos, which can promote dendritic
arborization at the expense of axon formation
(Howard et al. 2005); our findings suggest
that diazinon may be distinctly different from
chlorpyrifos in that regard. Potentially, these
possibilities can be resolved with detailed mor-
phologic techniques, but those hardly lend
themselves to rapid screening.
With the initiation of differentiation upon
addition of NGF to the cultures, the spectrum
of actions of the various agents underwent a
distinct transition. For DNA synthesis, the rate
of [3H]thymidine incorporation fell precipi-
tously, as would be expected from the transi-
tion from cell replication to differentiation.
During the transition, we again compared the
organophosphates to physostigmine; although
all the agents still produced signiﬁcant inhibi-
tion of DNA synthesis, physostigmine now
became the most effective of the agents and,
unlike the situation in undifferentiated cells,
did not show an adaptive loss of effect. This
pattern is consistent with in vivo findings,
which indicate that the effects of organophos-
phates on DNA synthesis undergo a switch
from noncholinergic to cholinergic mecha-
nisms as differentiation proceeds (Slotkin
1999, 2004a, 2004b, 2005; Whitney et al.
1995). Physostigmine, like the organophos-
phates, is a cholinesterase inhibitor; therefore,
under these circumstances, the most relevant
factor may simply be the much lower binding
of physostigmine to serum proteins, which
makes its bioeffective concentration higher
than that of the organophosphates (Whelpton
and Hurst 1990). Despite the fact that the
overall rate of DNA synthesis was far lower in
differentiating cells, prolonged exposure to any
of the agents reduced the total number of cells
as monitored by DNA content. Again, the
effect on DNA synthesis could not explain the
rank order of effects on cell number, for which
the greatest effects were seen with chlorpyrifos
Slotkin et al.
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ber by about 40%, followed by diazinon,
parathion and physostigmine, with Ni2+ pro-
viding the smallest reduction. Notably, despite
the fact that the DNA synthetic rate was lower
in differentiating cells than in the undifferenti-
ated state, the magnitude of the effects on cell
number were greater during differentiation
and, consequently, other factors contribute to
the cell deﬁcits. In earlier work with chlorpyri-
fos, we showed that the peak period of sensi-
tivity occurs at the initiation of differentiation,
where actions are exerted simultaneously
through noncholinergic and cholinergic mech-
anisms (Jameson et al. 2006b; Qiao et al.
2001). Accompanying the reduction in cell
numbers, there was an increase in cell size
(protein/DNA ratio) for each agent, again sug-
gesting that in differentiating cells—as in undif-
ferentiated cells—there is no direct suppression
of cell growth, nor was there evidence for loss of
viability in the trypan blue test. In earlier work
with chlorpyrifos, we found that inhibition of
cell growth can occur, but only at higher con-
centrations than those used here (Song et al.
1998). However, for the membrane/total pro-
tein ratio, the nonorganophosphate agents
caused an initial reduction in differentiating
cells; because this was superimposed on an
increase in protein/DNA, the results are consis-
tent with larger cell bodies. With continued
exposure, this effect disappeared, and for three
agents (chlorpyrifos, parathion, dieldrin),
there were increases in the membrane/total
protein ratio. Obviously, then, superimposed
on the deficits in cell number, there are
changes in membrane complexity as differenti-
ation proceeds, in a manner consistent with
targeting of intracellular organelles and/or
neuritic outgrowth. As discussed for some of
the other findings, resolution of these issues
requires morphologic determinations, which
are thus not amenable to rapid screening; at
the same time, the fact that these types of
changes are detectable at the biochemical level
lends support to the use of such indices.
Notably, these measures strengthen the view
that there are distinct differences among the
various organophosphates, with diazinon
showing unique properties; yet, at the same
time, there is a resemblance of outcomes
between some of the organophosphates and
developmental neurotoxicants from different
classes of compounds.
We conducted two additional sets of stud-
ies in differentiating cells that reinforce these
conclusions. First, we examined TBARS as an
index of lipid peroxidation with the idea that
oxidative stress and resultant membrane dam-
age could represent a common mechanism
underlying the neurotoxicant actions of oth-
erwise disparate compounds, especially in
light of the prominence of oxidative stress in
the noncholinesterase-related targets of
organophosphates (Gupta 2004). Indeed, all
of the agents except Ni2+ showed a signiﬁcant
increase in TBARS after 6 days in culture.
Uniquely, Ni2+ reduced TBARS, perhaps
because nickel can exist in higher oxidation
states, thus acting as a reductant in the culture
system. Accordingly, taken in isolation, lipid
peroxidation cannot explain commonalities
between neurotoxicant end points of Ni2+
and the other agents. Nevertheless, it should
be noted that earlier effects may go unnoticed
and that we did not assess oxidative damage
to cellular components other than membrane
lipids (e.g., DNA). Again, the principle is that
we are examining those aspects of neuro-
development that lend themselves to rapid
screening rather than investigating every
potential mechanism of action.
The second set of studies concerned effects
on the neurotransmitter phenotypic fate of the
cells. In earlier work, we found that both
chlorpyrifos and physostigmine suppress the
expression of the cholinergic phenotype in
favor of the catecholaminergic phenotype,
thus raising the TH/ChAT ratio (Jameson
et al. 2006b). The same change in cate-
cholaminergic/cholinergic balance occurs with
chlorpyrifos treatment in vivo (Dam et al.
1999; Meyer et al. 2004; Slotkin 2004a;
Slotkin et al. 2005). Here, we found the same
effects for all of the agents, with Ni2+ produc-
ing the largest shift in phenotype. Given the
disparate nature of the various compounds
tested here, it is highly unlikely that they all
share the same speciﬁc targeting of gene pro-
moters for the two phenotypes and rather, it
appears that the cholinergic phenotype is sim-
ply far more vulnerable to neurotoxicant
actions than is the catecholaminergic pheno-
type. In turn, this may explain why a wide
variety of developmental neurotoxicants all
seem to produce a similar pattern of cognitive
defects that center around cholinergic synaptic
function in key areas such as the hippocampus
(Eriksson 1997; Hohmann and Berger-
Sweeney 1998; Morley and Happe 2000;
Slotkin 2004a; Wessler et al. 1999; Yanai et al.
2002, 2004). The TH/ChAT index also sup-
ports the ability of the PC12 test system to
readily distinguish toxicant effects that alter
transmitter choice during neural cell differen-
tiation, an effect that could readily contribute
to the “miswiring” of key brain areas and
resultant neurobehavioral deﬁcits.
In conclusion, our results show the utility
of the PC12 cell model as a potential screen for
developmental neurotoxicants. This cell line
allows for distinctions to be made between
effects exerted on cell replication as compared
to the more complex panoply of events occur-
ring during differentiation, and can be applied
to completely different classes of compounds.
For the agents examined here, we were able to
distinguish rank-order effects among different
organophosphates and similarities and differ-
ences from a carbamate, which, although not
an organophosphate, shares the ability to
inhibit cholinesterase. Perhaps equally valuable,
we showed how many features of develop-
mental neurotoxicity are shared by an organo-
chlorine (dieldrin) and a metal (Ni2+), thus
leading to a number of predictions about the
effects of these agents on brain development
that can be tested in vivo. Nevertheless, it is
important to distinguish between the use of
cell lines that may be useful for screening of
neurotoxicants and the potential for high-
throughput techniques that would actually be
required to have an impact for evaluation of
the developmental neurotoxicity of the thou-
sands of new chemical entities released each
year. With regard to the end points used here,
the radiometric techniques would need to be
replaced by optical methods that lend them-
selves to detection with assay robots; certainly,
there are far more potential end points of inter-
est than those evaluated in the present study,
such as apoptosis, development of receptors
and ion channels, and dendritic arborization.
Nor would it suffice to use only the PC12
model, as other cell systems may be required
to evaluate the panoply of potential neurotoxic
effects. Instead, a stepwise screening procedure
is likely to be the best approach (Colborn
2006; Costa 1998, 2006; Slotkin 2004b): cell
culture results can be followed by rapid screen-
ing in lower organisms such as zebrafish
(Linney et al. 2004) and sea urchin (Buznikov
et al. 2003), thus reducing the number of
chemicals that ultimately need to be tested in
mammals and narrowing the focus to enable
better detection of the likely targets and end
points in the mammalian brain. The results
presented here, even though they involve only
a handful of test compounds and end points
in a single cell line, demonstrate the feasibility
of one step in the development of a rapid
in vitro screening procedure that may ulti-
mately enable this type of sequential approach
to tackle the problem of evaluating the thou-
sands of potentially neurotoxic chemicals in
the environment.
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